Salisbury Bancorp (NASDAQ:SAL) reported quarterly earnings of $0.75 per share. This is a 25 percent increase over earnings of $0.60 per share from the same period last year.
Novavax’s Covid-19 Vaccine Cleared For Use In New Zealanders Aged 12-17
New Zealand’s Medsafe has granted expanded provisional approval for Novavax Inc’s (NASDAQ:NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine in adolescents aged 12 through 17.…